The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site

Matrix Biology

Volumn 23, Issue 8, 2005, Pages 499-505

  Akiyama, Haruhiko ^a   Kamitani, Tetsu ^a   Yang, Xiaohong ^a   Kandyil, Roshini ^a   Bridgewater, Laura C ^b   Fellous, Marc ^c   Mori Akiyama, Yuko ^a   De Crombrugghe, Benoit ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c INSERM   (France)

Author keywords

Mutagenesis; Sox9; Ubiquitin proteasome system

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; TRANSCRIPTION FACTOR SOX9; UBIQUITIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE CONSTRUCT; INDUCED MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; COS CELLS; ENHANCER ELEMENTS (GENETICS); HIGH MOBILITY GROUP PROTEINS; HUMANS; MICE; MICE, INBRED C3H; MICROSCOPY, FLUORESCENCE; MUTATION; PROMOTER REGIONS (GENETICS); PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; RATS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UBIQUITIN;

VERTEBRATA;

EID: 13444260932     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2004.10.002     Document Type: Article

References (33)

1. H. Aberle, A. Bauer, J. Stappert, A. Kispert, and R. Kemler Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J. 16 1997 3797 3804
2. O. Abu Hatoum, S. Gross-Mesilaty, K. Breitschopf, A. Hoffman, H. Gonen, A. Ciechanover, and E. Bengal Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding Mol. Cell. Biol. 18 1998 5670 5677
3. H. Akiyama, M.C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6 Genes Dev. 16 2002 2813 2828
4. H. Akiyama, J.P. Lyons, Y. Mori-Akiyama, X. Yang, R. Zhang, Z. Zhang, J.M. Deng, M.M. Taketo, T. Nakamura, R.R. Behringer, P.D. McCrea, and B. De Crombrugghe Interactions between Sox9 and {beta}-catenin control chondrocyte differentiation Genes Dev. 18 2004 1072 1087
5. Y. Ben-Neriah Regulatory functions of ubiquitination in the immune system Nat. Immunol. 3 2002 20 26
6. W. Bi, J.M. Deng, Z. Zhang, R.R. Behringer, and B. de Crombrugghe Sox9 is required for cartilage formation Nat. Genet. 22 1999 85 89
7. W. Bi, W. Huang, D.J. Whitworth, J.M. Deng, Z. Zhang, R.R. Behringer, and B. de Crombrugghe Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization Proc. Natl. Acad. Sci. U. S. A. 98 2001 6698 6703
8. C.E. Bishop, D.J. Whitworth, Y. Qin, A.I. Agoulnik, I.U. Agoulnik, W.R. Harrison, R.R. Behringer, and P.A. Overbeek A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse Nat. Genet. 26 2000 490 494
9. J.W. Foster, M.A. Dominguez-Steglich, S. Guioli, G. Kowk, P.A. Weller, M. Stevanovic, J. Weissenbach, S. Mansour, I.D. Young, and P.N. Goodfellow Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene Nature 372 1994 525 530
10. S. Gasca, J. Canizares, P. De Santa Barbara, C. Mejean, F. Poulat, P. Berta, and B. Boizet-Bonhoure A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination Proc. Natl. Acad. Sci. U. S. A. 99 2002 11199 11204
11. T. Hattori, N. Ohoka, Y. Inoue, H. Hayashi, and K. Onozaki C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer Oncogene 22 2003 1273 1280
12. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
13. C.S. Houston, J.M. Opitz, J.W. Spranger, R.I. Macpherson, M.H. Reed, E.F. Gilbert, J. Herrmann, and A. Schinzel The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971 Am. J. Med. Genet. 15 1983 3 28
14. W. Huang, X. Zhou, V. Lefebvre, and B. de Crombrugghe Phosphorylation of Sox9 by cyclic AMP-dependent protein kinase A enhances Sox9's ability to transactivate a Col2a1 chondrocyte-specific enhancer Mol. Cell. Biol. 20 2000 4149 4158
15. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-kB activity Annu. Rev. Immunol. 18 2000 621 663
16. V. Lefebvre, W. Huang, V.R. Harley, P.N. Goodfellow, and B. de Crombrugghe SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene Mol. Cell. Biol. 17 1997 2336 2346
17. J.M. Lingbeck, J.S. Trausch-Azar, A. Ciechanover, and A.L. Schwartz Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD J. Biol. Chem. 278 2003 1817 1823
18. C.G. Maki, J.M. Huibregtse, and P.M. Howley In vivo ubiquitination and proteasome-mediated degradation of p53(1) Cancer Res. 56 1996 2649 2654
19. O.J. Marshall, and V.R. Harley Molecular mechanisms of SOX9 action Mol. Genet. Metab. 71 2000 455 462
20. J. Meyer, P. Sudbeck, M. Held, T. Wagner, M.L. Schmitz, F.D. Bricarelli, E. Eggermont, U. Friedrich, O.A. Haas, A. Kobelt, J.G. Leroy, L. Van Maldergem, E. Michel, B. Mitulla, R.A. Pfeiffer, A. Schinzel, H. Schmidt, and G. Scherer Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations Hum. Mol. Genet. 6 1997 91 98
21. Y. Mori-Akiyama, H. Akiyama, D.H. Rowitch, and B. De Crombrugghe Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest Proc. Natl. Acad. Sci. U. S. A. 100 2003 9360 9365
22. L.J. Ng, S. Wheatley, G.E. Muscat, J. Conway-Campbell, J. Bowles, E. Wright, D.M. Bell, P.P. Tam, K.S. Cheah, and P. Koopman SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse Dev. Biol. 183 1997 108 121
23. D.K. Panda, D. Miao, V. Lefebvre, G.N. Hendy, and D. Goltzman The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells J. Biol. Chem. 276 2001 41229 41236
24. K. Piper, S.G. Ball, J.W. Keeling, S. Mansoor, D.I. Wilson, and N.A. Hanley Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia Mech. Dev. 116 2002 223 226
25. K.M. Sakamoto Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies Mol. Genet. Metab. 77 2002 44 56
26. S.E. Salghetti, S.Y. Kim, and W.P. Tansey Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc EMBO J. 18 1999 717 726
27. I. Stancovski, H. Gonen, A. Orian, A.L. Schwartz, and A. Ciechanover Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes Mol. Cell. Biol. 15 1995 7106 7116
28. P. Stelter, and H.D. Ulrich Control of spontaneous and damage-induced mutagenasis by SUMO and ubiquitin conjugation Nature 425 6954 2003 188 191
29. C.C. Stolt, P. Lommes, E. Sock, M.C. Chaboissier, A. Schedl, and M. Wegner The Sox9 transcription factor determines glial fate choice in the developing spinal cord Genes Dev. 17 2003 1677 1689
30. P. Sudbeck, and G. Scherer Two independent nuclear localization signals are present in the DNA-binding high-mobility group domains of SRY and SOX9 J. Biol. Chem. 272 1997 27848 27852
31. T. Wagner, J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F.D. Bricarelli, J. Keutel, and E. Hustert Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 Cell 79 1994 1111 1120
32. E.T. Yeh, L. Gong, and T. Kamitani Ubiquitin-like proteins: new wines in new bottles Gene 248 2000 1 14
33. Q. Zhao, H. Eberspaecher, V. Lefebvre, and B. De Crombrugghe Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis Dev. Dyn. 209 1997 377 386